Unlocking the Future of the Mineral And Bone Disorder Treatment Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
Analyzing the Growth Rate of the Mineral And Bone Disorder Treatment Market: What’s the Expected CAGR for the Next Decade?
There has been a robust growth in the market size of mineral and bone disorder treatments in the past years. The market, which was valued at $3.3 billion in 2024, is projected to witness an increase to $3.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.7%. Factors contributing to the historical growth include the prevalence of chronic kidney disease, an aging global population, heightened awareness surrounding mineral and bone disorders, increased accessibility to treatments for these disorders, and a rise in disposable income levels.
Anticipated to witness robust expansion in the forthcoming years, the market size for treatment of mineral and bone disorders is predicted to escalate to $4.68 billion by 2029, with a compound annual growth rate (CAGR) of 7.1%. The surge in this projection period can be credited to the escalating requirement for quality life treatments, the burgeoning need for individualized medication, government’s investment in healthcare, and a growing comprehension of early diagnosis’ significance. The main trends that will be visible during this prediction period encompass progress in medical investigation, advances in pharmaceuticals, the rise of digital health, biological therapies, telehealth, and distant monitoring.
What Combination of Drivers Is Leading to Accelerated Growth in the Mineral And Bone Disorder Treatment Market?
The aging population is predicted to contribute to the expansion of the mineral and bone disorder treatment market. Those aged 65 and above, known as the elderly demographic, often suffer from the loss of muscle and bone mass which results in reduced strength and frailty. Administering treatments for bone and mineral disorders can counteract age-related muscle, bone and joint changes, reinforce bones and slow down the rate of bone loss. For example, the UK Parliament’s House of Commons Library reported in July 2024 that in 2022, 12.7 million individuals, which constitutes 19% of the total population, will be 65 or older in the UK. This number is predicted to increase to 22.1 million by 2072, accounting for 27% of the population. This surge in the elderly population is subsequently supporting the growth of the mineral and bone disorder treatment market.
Prominence of Chronic Kidney Diseases Bolsters the Mineral And Bone Disorder Treatment Market
The rising occurrence of chronic kidney diseases (CKD) is anticipated to fuel the growth of the mineral and bone disorder treatment market. CKD is a long-term, progressive illness where the kidneys slowly lose their functionality. The primary objectives of treating mineral and bone disorders in patients with chronic kidney disease are to retain balanced mineral levels, maintain bone health and lower the risk of complications linked to these imbalances. As per the data from the National Library of Medicine in March 2022, over 800 million people globally, making up 10% of the total population, suffer from chronic kidney disease, which is categorized as a degenerative disorder. Therefore, this upsurge in chronic kidney diseases is propelling the growth of the mineral and bone disorder treatment market.
Explore Comprehensive Insights Into The Global Mineral And Bone Disorder Treatment Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12956&type=smp
What Are the Leading Organizations Impacting the Mineral And Bone Disorder Treatment Market’s Growth?
Major companies operating in the mineral and bone disorder treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Co. Ltd., Eli Lilly And Company, Amgen Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Servier Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Cadila Healthcare Ltd., Alembic Pharmaceuticals Limited, Ajanta Pharma Ltd., Abiogen Pharma Spa, Melinta Therapeutics Inc., Intas Pharmaceuticals Ltd., Radius Health Inc., EffRx Pharmaceuticals SA.
What Are the Most Prominent Trends Driving Change in the Mineral And Bone Disorder Treatment Market?
Major players in the mineral and bone disorder treatment industry are concentrating on the creation and approval of new products to solidify their place in the market. There’s a rise in drug approval for mineral and bone disorders, attributable to the growing elderly demographic and increasing chronic kidney diseases prevalence; an example being TYMLOS (abaloparatide) which carries the active ingredient abaloparatide, a synthetic version of the human parathyroid hormone. For instance, in December 2022, Radius Health Inc., an American biopharmaceutical enterprise, secured approval for TYMLOS (abaloparatide), a parathyroid hormone-related peptide [PTHrP(1-34)] analog, aimed at enhancing bone density in men diagnosed with osteoporosis and at high fracture risk. It functions as a bone anabolic agent, selectively activating the parathyroid hormone 1 receptor (PTH1R) found in osteoblasts and osteocytes, subsequently leading to elevated bone formation and density.
Secure Your Global Mineral And Bone Disorder Treatment Market Report Now for Fast and Efficient Delivery!
Which Key Market Segments Comprise the Mineral And Bone Disorder Treatment Market and Drive Its Revenue Growth?
The mineral and bone disorder treatment market covered in this report is segmented –
1) By Treatment: Diet, Nutrition, Medication, Supplements, Dialysis
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Diet: Calcium-Rich Foods, Vitamin D-Enriched Foods, Phosphorus-Rich Foods
2) By Nutrition: Nutritional Counseling, Fortified Food Products, Meal Replacement Programs
3) By Medication: Bisphosphonates, Hormonal Therapies, RANK Ligand Inhibitors
4) By Supplements: Calcium Supplements, Vitamin D Supplements, Multivitamin Supplements
5) By Dialysis: Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy (CRRT)
What Regions Are Leading the Charge in the Mineral And Bone Disorder Treatment Market?
North America was the largest region in the mineral and bone disorder treatment market in 2024. The regions covered in mineral and bone disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does the Definition of the Mineral And Bone Disorder Treatment Market Include?
Mineral and bone disorder treatment refers to a treatment procedure recommended when there is an imbalance in the levels of calcium and phosphorus in the blood. The treatment regulates the levels of certain minerals and hormones in the blood to prevent bone and blood vessel damage.
Browse Through More Similar Reports By The Business Research Company:
Blood Collection Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
Blood Culture Tests Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
